NFκB is persistently active in a number of human diseases, including sepsis, cancer, arthritis, chronic inflammation, asthma, neurodegenerative diseases, metabolic disease, and heart disease8, 9, 10, and thus, effective and safe inhibitors of NFκB would have wide-ranging therapeutic use. Here, NFKB1 is linked to cancer.